Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IL
$ 7.29
6.11 %
$ 9.29 M
Market Cap
-0.02
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
178.73%
EBIT
Estimate
--79.24%
Net Income
Estimate
-0.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
RedHill Biopharma Ltd.
RDHL has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart RDHL
EBIT FORECAST
EBIT Forecast Chart RDHL
NET INCOME FORECAST
Net Income Chart RDHL